Filippo Birocchi PhD

Filippo Birocchi graduated in Biotechnology and later in Medical and Pharmaceutical Biotechnology at the University of Genova (Italy). In 2017, he joined Luigi Naldini’s Lab at the San Raffaele Telethon Institute for Gene Therapy (Milan, Italy) for his PhD. During his experience in Naldini’s Lab, he focused his studies on the development of an inducible tumor-targeted delivery gene therapy platform for the treatment of Glioblastoma. Currently, he is working on novel chemokine-based technologies to increase the infiltration and function of CAR-T cells in solid tumors.